DUBLIN–(BUSINESS WIRE)–The “Respiratory Infection Diagnostic Markets by Technology, Plex, Place, Product and by Region With Covid-19 Impact & Forecasting/Analysis, and Executive and Consultant Guides 2021-2025” report has been added to ResearchAndMarkets.com’s offering.

COVID-19 has broken open the market for point of care testing of respiratory infections. Now the competition for market share begins in earnest. Large new markets are opening up. In health facilities, clinics, physicians’ offices and elsewhere. And lets not forget the screening market, not just for COVID, but for the rest of the 20 something respiratory pathogens as well. Multiplex vs single plex? Explore the rapidly changing market as competitors jockey for position in new markets that are not yet well understood.

New technology is forever changing the diagnosis of respiratory infections. Shrinking time to result is opening up markets multiple times the size of current microbiology based practice. Diagnosis has already moved into the Emergency Room. It is now moving to the Physician’s Office Lab. Could the Home be next?

The Multiplex factor is creating market confusion while lowering costs and improving care but important factors are holding back progress. The widespread nature of respiratory infections, (young people can get 8 colds a year) means that potential market sizes are enormous. Respiratory, already the largest infectious disease category could multiply in size. This is a growth opportunity for all diagnostic companies. Understand the opportunity and the risk with this in depth report.

Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don’t worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges.

Companies Mentioned

• Abacus Diagnostica
• Abbott Diagnostics
• Accelerate Diagnostics
• Ador Diagnostics
• Akonni Biosystems
• Alveo Technologies
• Applied BioCode
• Aus Diagnostics
• Beckman Coulter Diagnostics
• Becton, Dickinson and Company
• Binx Health
• Biocartis
• bioMerieux Diagnostics
• Bio-Rad Laboratories, Inc.
• Bosch Healthcare Solutions GmbH
• Cepheid (now Danaher)
• Co Diagnostics
• Credo Diagnostics Biomedical
• Cue Health
• Curetis N.V. / Curetis GmbH
• Diagenode Diagnostics
• Diascopic
• Diasorin S.p.A
• Enzo Life Sciences, Inc
• Eurofins Scientific
• Fluxergy
• Fulgent Genetics
• Fusion Genomics
• Genetic Signatures
• GenMark Dx
• Hibergene Diagnostics
• Hologic
• Immunexpress
• Inflammatix
• Invetech
• Janssen Diagnostics
• Karius
• Lexagene
• LightDeck Diagnostics
• Luminex Corp
• Lumos Diagnostics
• Mammoth Biosciences
• Maxim Biomedical
• Meridian Bioscience
• Mesa Biotech
• Millipore Sigma
• Mindray
• Mobidiag
• Mologic
• Nanomix
• Operon
• Oxford Nanopore Technologies
• Panagene
• Perkin Elmer
• Primerdesign
• Prominex
• Qiagen Gmbh
• Quantumdx
• Quidel
• Roche Molecular Diagnostics
• Saw Diagnostics
• Seegene
• Siemens Healthineers
• Sona Nanotech
• SpeeDx
• T2 Biosystems
• Thermo Fisher Scientific Inc.
• Veramarx
• Veredus Laboratories
• Visby Medical
• XCR Diagnostics

Key Topics Covered:

1 Market Guides

2 Introduction and Market Definition

3 Market Overview

4 Market Trends

4.1 Factors Driving Growth

4.1.1 Syndromic Multiplexing

4.1.2 T.A.T

4.1.3 Antimicrobial Resistance Movement

4.1.4 Pandemic Mitigation

4.1.5 An Aging at Risk Population

4.2 Factors Limiting Growth

4.2.1 The Cost Curve

4.2.2 Regulation and coverage

4.2.3 Laissez Faire

4.3 Instrumentation and Automation

4.3.1 The Shrinking Multiplexing Machine

4.3.2 Bioinformatics Networking and Anonymous Reporting

4.4 Diagnostic Technology Development

4.4.1 The Key Role of Time to Result

4.4.2 Single Cell Genomics Changes the Picture

4.4.3 Pharmacogenomics Blurs Diagnosis and Treatment

4.4.4 Pathogen Identification – A Projected Timetable of the Future

5 Respiratory Infection Diagnostics Recent Developments

6 Profiles of Key Players

7 The Global Market for Respiratory Infection Diagnostics

8 Global Respiratory Infection Diagnostic Markets – By Technology

9 Global Respiratory Infection Diagnostic Markets – by Plex

10 Global Respiratory Infection Diagnostic Markets – by Place

11 Global Respiratory Infection Diagnostic Markets – by Product

12 Appendices

For more information about this report visit https://www.researchandmarkets.com/r/z1qb15